NEW YORK -- Scientists have finally recovered stem cells from cloned human embryos, a longstanding goal that could lead to new treatments for such ill...
WASHINGTON -- The Supreme Court won't stop the government's funding of embryonic stem cell research, despite some researchers' complaints that the wor...
What would you do, if you found an enemy in your house?
Would you let him move in and take over--or encourage him to vacate the premises?
Regarding ...
One of the more memorable ads this election is the House Majority PAC's attack on Coffman for opposing embryonic stem cell research. In its Truth Test on this topic, 9News should have said more about the ramifications of Coffman's position.
Linked up with the others, Coffman and Coors could do considerable damage to medical research, women's rights, and the dreams of family for childless couples. Fortunately, democracy provides us a remedy. Remember in November!
There was a time when Republicans supported our program overwhelmingly -- let us hope those better days return, after the election. To paraphrase another California Governor: "We'll be back!"
Romney has an opportunity to break with the more extreme elements of his party on an issue that has consistently shown to be important to the American people, and one that he supported for a time as governor: federal embryonic stem cell research.
Both Newt Gingrich and Mitt Romney supported embryonic stem cell research in the past. Both men, attempting to gain political advancement, have flip-flopped on the issue. But there is an important difference between the two men.
Cute and cuddly, little Hex, Roku, and Chimero look just like any other rhesus monkeys. But they carry distinctive DNA - a mashup of genes from severa...
Sherley vs. Sebelius, a lawsuit threatening stem cell research, was thrown out today. With Judge Lamberth's ruling, state dollars can once again be matched by federal contributions.
Nancy Pelosi is a woman who broke the glass ceiling, who will stand up for what is right--but who is also never afraid to sit down and talk, and figure out a better way.
Our collective experience of the stem cell controversy has been instructive in yielding an approval process that will allow the science to move forward in way that deserves the nation's trust.
Now the hard part begins: implementing a stem-cell policy that's meaningful, has full ethical protections and unlocks the scientific talent that's been held back the last eight years.